Literature DB >> 20517601

Effect of hydrolysis on identifying prenatal cannabis exposure.

Teresa R Gray1, Allan J Barnes, Marilyn A Huestis.   

Abstract

Identification of prenatal cannabis exposure is important due to potential cognitive and behavioral consequences. A two-dimensional gas chromatography-mass spectrometry method for cannabinol, Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), 8beta,11-dihydroxy-THC, and 11-nor-9-carboxy-THC (THCCOOH) quantification in human meconium was developed and validated. Alkaline, enzymatic, and enzyme-alkaline tandem hydrolysis conditions were optimized with THC- and THCCOOH-glucuronide reference standards. Limits of quantification ranged from 10 to 15 ng/g, and calibration curves were linear to 500 ng/g. Bias and intra-day and inter-day imprecision were <12.3%. Hydrolysis efficiencies were analyte-dependent; THC-glucuronide was effectively cleaved by enzyme, but not base. Conversely, THCCOOH-glucuronide was most sensitive to alkaline hydrolysis. Enzyme-alkaline tandem hydrolysis maximized efficiency for both glucuronides. Identification of cannabinoid-positive meconium specimens nearly doubled following alkaline and enzyme-alkaline hydrolysis. Although no 11-OH-THC glucuronide standard is available, enzymatic hydrolysis improved 11-OH-THC detection in authentic specimens. Maximal identification of cannabis-exposed neonates and the widest range of cannabis biomarkers are achieved with enzyme-alkaline tandem hydrolysis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20517601      PMCID: PMC3163086          DOI: 10.1007/s00216-010-3772-y

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  16 in total

Review 1.  Bioanalytical procedures for monitoring in utero drug exposure.

Authors:  Teresa Gray; Marilyn Huestis
Journal:  Anal Bioanal Chem       Date:  2007-03-17       Impact factor: 4.142

2.  Quantification of Delta9-tetrahydrocannabinol and its major metabolites in meconium by gas chromatographic-mass spectrometric assay: assay validation and preliminary results of the "meconium project".

Authors:  Emilia Marchei; Manuela Pellegrini; Roberta Pacifici; Ilaria Palmi; Jaime Lozano; Oscar García-Algar; Simona Pichini
Journal:  Ther Drug Monit       Date:  2006-10       Impact factor: 3.681

3.  Simultaneous GC-EI-MS determination of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis.

Authors:  Tsadik T Abraham; Ross H Lowe; Stephane O Pirnay; William D Darwin; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2007-10       Impact factor: 3.367

4.  Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry.

Authors:  Garry Milman; Allan J Barnes; Ross H Lowe; Marilyn A Huestis
Journal:  J Chromatogr A       Date:  2010-01-04       Impact factor: 4.759

Review 5.  Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations.

Authors:  Patrizia Campolongo; Viviana Trezza; Maura Palmery; Luigia Trabace; Vincenzo Cuomo
Journal:  Int Rev Neurobiol       Date:  2009       Impact factor: 3.230

6.  Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC.

Authors:  Eugene W Schwilke; David M Schwope; Erin L Karschner; Ross H Lowe; William D Darwin; Deanna L Kelly; Robert S Goodwin; David A Gorelick; Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-10-15       Impact factor: 8.327

7.  delta 9-THC metabolites in meconium: identification of 11-OH-delta 9-THC, 8 beta,11-diOH-delta 9-THC, and 11-nor-delta 9-THC-9-COOH as major metabolites of delta 9-THC.

Authors:  M A ElSohly; S Feng
Journal:  J Anal Toxicol       Date:  1998 Jul-Aug       Impact factor: 3.367

8.  Cannabinoids in humans. II. The influence of three methods of hydrolysis on the concentration of THC and two metabolites in urine.

Authors:  P M Kemp; I K Abukhalaf; J E Manno; B R Manno; D D Alford; M E McWilliams; F E Nixon; M J Fitzgerald; R R Reeves; M J Wood
Journal:  J Anal Toxicol       Date:  1995-09       Impact factor: 3.367

9.  Confirmation of cannabinoids in meconium using two-dimensional gas chromatography with mass spectrometry detection.

Authors:  Stephanie J Marin; Rebecka Coles; Francis M Urry; Gwendolyn A McMillin
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-08-26       Impact factor: 3.205

10.  Characterization of human hepatic and extrahepatic UDP-glucuronosyltransferase enzymes involved in the metabolism of classic cannabinoids.

Authors:  Anna Mazur; Cheryl F Lichti; Paul L Prather; Agnieszka K Zielinska; Stacie M Bratton; Anna Gallus-Zawada; Moshe Finel; Grover P Miller; Anna Radomińska-Pandya; Jeffery H Moran
Journal:  Drug Metab Dispos       Date:  2009-04-01       Impact factor: 3.922

View more
  7 in total

1.  Antiretroviral Drugs in Meconium: Detection for Different Gestational Periods of Exposure.

Authors:  Sarah K Himes; Katherine Tassiopoulos; Ram Yogev; Marilyn A Huestis
Journal:  J Pediatr       Date:  2015-05-19       Impact factor: 4.406

2.  Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry.

Authors:  David M Schwope; Karl B Scheidweiler; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2011-07-05       Impact factor: 4.142

3.  Identifying prenatal cannabis exposure and effects of concurrent tobacco exposure on neonatal growth.

Authors:  Teresa R Gray; Rina D Eiden; Kenneth E Leonard; Gerard J Connors; Shannon Shisler; Marilyn A Huestis
Journal:  Clin Chem       Date:  2010-07-13       Impact factor: 8.327

4.  Cannabinoids in exhaled breath following controlled administration of smoked cannabis.

Authors:  Sarah K Himes; Karl B Scheidweiler; Olof Beck; David A Gorelick; Nathalie A Desrosiers; Marilyn A Huestis
Journal:  Clin Chem       Date:  2013-09-17       Impact factor: 8.327

5.  Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine.

Authors:  Mateus M Bergamaschi; Allan Barnes; Regina H C Queiroz; Yasmin L Hurd; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2013-03-15       Impact factor: 4.142

6.  Prenatal tobacco exposure, biomarkers for tobacco in meconium, and neonatal growth outcomes.

Authors:  Sarah K Himes; Laura R Stroud; Karl B Scheidweiler; Raymond S Niaura; Marilyn A Huestis
Journal:  J Pediatr       Date:  2012-12-01       Impact factor: 4.406

Review 7.  Pharmacokinetics of Cannabis and Its Derivatives in Animals and Humans During Pregnancy and Breastfeeding.

Authors:  Anaëlle Monfort; Ema Ferreira; Grégoire Leclair; Gregory Anton Lodygensky
Journal:  Front Pharmacol       Date:  2022-07-12       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.